Trial intelligence / Profile preview

Paclitaxel, Cisplatin, and 5-Fluorouracil in Advanced or Recurrent SCCHN

NCT00006248Phase 2Completed

Sponsor
SWOG Cancer Research Network
Start
Nov 2000
Primary completion
Jun 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of paclitaxel, cisplatin, fluorouracil in squamous cell carcinoma of the head and neck (HNSCC), sponsored by SWOG Cancer Research Network. Started Nov 2000; status: completed.

02

Drugs

paclitaxelcisplatinfluorouracil
03

Conditions

squamous cell carcinoma of the head and neck (HNSCC)

Beyond the preview

Go deeper on NCT00006248.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00006248.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call